Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

AI Image Maker Sora 2 Sparks Global ALARM! Can You Trust What You See Anymore?

Tech

|

Updated on 11 Nov 2025, 05:49 pm

Whalesbook Logo

Reviewed By

Abhay Singh | Whalesbook News Team

Short Description:

OpenAI's new AI video tool, Sora 2, is raising serious concerns globally. Advocacy groups like Public Citizen are demanding its withdrawal due to its potential to create realistic deepfakes, spread misinformation, and harm privacy and democracy. The technology has already been used to generate disturbing content, and critics argue OpenAI is releasing unsafe products too quickly.
AI Image Maker Sora 2 Sparks Global ALARM! Can You Trust What You See Anymore?

▶

Detailed Coverage:

OpenAI's new AI video generation tool, Sora 2, is drawing significant criticism from advocacy groups, academics, and the entertainment industry. The platform allows users to create videos from text prompts, raising serious concerns about the spread of realistic deepfakes, nonconsensual imagery, and low-quality "AI slop." The nonprofit Public Citizen has formally urged OpenAI to withdraw Sora 2, calling its rushed release a "consistent and dangerous pattern of rushing to market with a product that is either inherently unsafe or lacking in needed guardrails." They argue it shows "reckless disregard" for public safety, individual rights to likeness, and democratic stability.

Advocates like J.B. Branch warn of a future where trust in visual media erodes, impacting democracy. Privacy concerns are paramount, with reports of women being depicted in harmful content despite OpenAI blocking nudity. OpenAI has responded to previous outcries by implementing restrictions and making agreements regarding public figures and copyrighted characters, stating they aim to be conservative while society adjusts. However, critics argue OpenAI often releases products first and addresses safety issues afterward, a pattern also seen with its ChatGPT product, which faces lawsuits over alleged psychological manipulation.

Impact: This situation highlights the critical ethical challenges in rapid AI development. It may lead to increased regulatory pressure on AI platforms globally, affecting innovation, user privacy, and the integrity of digital information. The debate underscores the need for robust safety measures and responsible deployment of advanced AI technologies. Impact Rating: 8/10

Difficult Terms: * AI Image-Generation Platforms: Software that uses artificial intelligence to create images or videos from text descriptions. * Deepfakes: Realistic but fabricated videos or images created using AI, often depicting people saying or doing things they never did. * Nonconsensual Images: Images or videos created and shared without the permission of the person depicted. * AI Slop: A term used to describe a large volume of low-quality or nonsensical content generated by AI. * Guardrails: Safety measures or restrictions put in place to prevent misuse or harm from a technology. * Proliferation: The rapid increase in the number or spread of something. * Advocacy Groups: Organizations that publicly support or recommend a particular cause or policy. * SAG-AFTRA: The Screen Actors Guild‐American Federation of Television and Radio Artists, a labor union representing actors and other media professionals. * Copyrights: The exclusive legal right, given to an originator or an assignee to print, publish, perform, film, or record literary, artistic, or musical material, and to authorize others to do the same.


Healthcare/Biotech Sector

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Biocon's Q2 FY26 Triumph: Revenue Soars 20%, Biosimilars Lead Explosive Growth!

Biocon's Q2 FY26 Triumph: Revenue Soars 20%, Biosimilars Lead Explosive Growth!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Novo Nordisk SHOCKS India: Blockbuster Drug Wegovy Price SLASHED by 33% Amid Fierce Rivalry!

Novo Nordisk SHOCKS India: Blockbuster Drug Wegovy Price SLASHED by 33% Amid Fierce Rivalry!

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price CRASHED 37% in India! Novo Nordisk's Bold Move to Win Obesity Market?

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Wegovy Price SHOCK: Novo Nordisk Slashes India Costs Up to 37%! Diabetes & Obesity Drug Now More Affordable!

Biocon's Q2 FY26 Triumph: Revenue Soars 20%, Biosimilars Lead Explosive Growth!

Biocon's Q2 FY26 Triumph: Revenue Soars 20%, Biosimilars Lead Explosive Growth!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Motilal Oswal REITERATES BUY on Mankind Pharma: Rs 2800 Target & Growth Outlook Revealed!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Medikabazaar's Jaw-Dropping Comeback: From Heavy Losses to Record Profits and Global Ambitions!

Novo Nordisk SHOCKS India: Blockbuster Drug Wegovy Price SLASHED by 33% Amid Fierce Rivalry!

Novo Nordisk SHOCKS India: Blockbuster Drug Wegovy Price SLASHED by 33% Amid Fierce Rivalry!


Commodities Sector

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Hindustan Copper Q2 Profit Skyrockets 83% - Is This The Start Of A New Copper Boom?

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold & Silver Surge Continues? Expert Unveils 2025 Bull Run Secrets & Your Investment Strategy!

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

Gold ETFs EXPLODE: India's Gold Investment Crosses ₹1 Lakh Crore - Is This Your Next Big Opportunity?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

India's Gold Secret: Unlock $850 Billion and Rule Global Finance?

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!

EID Parry Stuns Investors: Massive Standalone Loss Revealed Amidst Soaring Consolidated Profits!